atenolol and Cirrhosis, Liver
atenolol has been researched along with Cirrhosis, Liver in 11 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Atenolol was given at a fixed dose of 100 mg/day." | 2.66 | Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study. ( Colombo, M; de Franchis, R; Sangiovanni, A; Tommasini, M, 1989) |
"She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome." | 2.41 | Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium. ( Hattori, K; Hirakawa, Y; Ichihashi, R; Kei, M; Matsubara, K; Saburi, Y; Sakurai, H; Tsukamoto, H; Yokouchi, K, 2000) |
" Hepatic pharmacokinetic modelling was performed with a two-phase physiologically-based organ pharmacokinetic model with the vascular space and dispersion evaluated with the MID technique." | 1.38 | Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage. ( Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Weiss, M; Zhang, Q, 2012) |
" Studies were undertaken using an in situ-perfused rat liver and multiple indicator dilution, and outflow data were analyzed with a physiologically based organ pharmacokinetic model." | 1.37 | Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. ( Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Thorling, CA; Zhang, Q, 2011) |
" Thus, plasma half-life after intravenous dosing of atenolol was 6." | 1.27 | Clinical experience with atenolol in patients with chronic liver disease. ( Braun, W; Kirch, W; Mutschler, E; Ohnhaus, EE; Schäfer-Korting, M, 1983) |
"The pharmacokinetic properties of propranolol and atenolol were evaluated both in 9 patients with cirrhosis and in 12 healthy subjects." | 1.27 | Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients. ( Decourt, S; Flouvat, B; Lebrec, D; Leneveu, A; Rocher, I; Rosier, SP, 1985) |
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Li, P | 2 |
Robertson, TA | 2 |
Thorling, CA | 1 |
Zhang, Q | 2 |
Fletcher, LM | 2 |
Crawford, DH | 2 |
Roberts, MS | 2 |
Weiss, M | 1 |
Mills, PR | 1 |
Rae, AP | 1 |
Farah, DA | 1 |
Russell, RI | 1 |
Lorimer, AR | 1 |
Carter, DC | 1 |
Kirch, W | 1 |
Schäfer-Korting, M | 1 |
Mutschler, E | 1 |
Ohnhaus, EE | 1 |
Braun, W | 1 |
Sakurai, H | 1 |
Kei, M | 1 |
Matsubara, K | 1 |
Yokouchi, K | 1 |
Hattori, K | 1 |
Ichihashi, R | 1 |
Hirakawa, Y | 1 |
Tsukamoto, H | 1 |
Saburi, Y | 1 |
Ljubicić, N | 1 |
Bilić, A | 1 |
Avezzano, ES | 1 |
Seefe, LB | 1 |
Tommasini, M | 1 |
de Franchis, R | 1 |
Sangiovanni, A | 1 |
Colombo, M | 1 |
Bonkovsky, HL | 1 |
Bonkovsky, ML | 1 |
Anderson, PB | 1 |
Rothstein, RI | 1 |
Erkkinen, JF | 1 |
Zoli, M | 1 |
Marchesini, G | 1 |
Marzocchi, A | 1 |
Marrozzini, C | 1 |
Dondi, C | 1 |
Pisi, E | 1 |
Rocher, I | 1 |
Decourt, S | 1 |
Leneveu, A | 1 |
Lebrec, D | 1 |
Rosier, SP | 1 |
Flouvat, B | 1 |
Reviews
2 reviews available for atenolol and Cirrhosis, Liver
Article | Year |
---|---|
Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Atrial Fibrillation; Bradycardia; Calcium Channel Block | 2000 |
Prevention of recurrent variceal hemorrhage: to block or not to block?
Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Prop | 1990 |
Trials
5 trials available for atenolol and Cirrhosis, Liver
Article | Year |
---|---|
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
Topics: Atenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hyperte | 1984 |
The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis.
Topics: Adult; Analysis of Variance; Atenolol; Blood Flow Velocity; Female; Humans; Labetalol; Liver Cirrhos | 1991 |
Prevention of recurrent variceal hemorrhage: to block or not to block?
Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Prop | 1990 |
Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Human | 1989 |
Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study.
Topics: Atenolol; Clinical Trials as Topic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Liv | 1989 |
Other Studies
5 other studies available for atenolol and Cirrhosis, Liver
Article | Year |
---|---|
Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cations; Cytochrome P-450 | 2011 |
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2012 |
Clinical experience with atenolol in patients with chronic liver disease.
Topics: Administration, Oral; Adult; Atenolol; Chronic Disease; Female; Humans; Injections, Intravenous; Kid | 1983 |
Portal pressure changes induced by medical treatment: US detection.
Topics: Adult; Atenolol; Blood Pressure; Esophageal and Gastric Varices; Female; Hepatic Veins; Humans; Live | 1985 |
Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients.
Topics: Adult; Atenolol; Cardiac Output; Depression, Chemical; Female; Half-Life; Hemodynamics; Humans; Kine | 1985 |